Amoclav Syrup
Formulation

 Co-amoxiclav (AmoClav®) 228.5 mg/5 mL suspension

After reconstitution, each 5 mL (1 teaspoonful) suspension contains:
Amoxicillin (as trihydrate) 200 mg
Clavulanic acid (as potassium clavulanate) 28.5 mg

 

Co-amoxiclav (AmoClav®) 457 mg/5 mL suspension

After reconstitution, each 5 mL (1 teaspoonful) suspension contains:
Amoxicillin (as trihydrate) 400 mg
Clavulanic acid (as potassium clavulanate) 57 mg

Co-amoxiclav

AmoClav® Suspension

Prescription Drug

Indication

For the treatment of the following infections caused by susceptible microorganisms:

  • Upper respiratory tract infections (including ENT infections): Tonsillitis, sinusitis, otitis media
  • Lower respiratory tract infections: Acute and chronic bronchitis, pneumonia, lung abscess
  • Genito-urinary tract and abdominal infections: Cystitis, urethritis, pyelonephritis, female genital infections, septic abortion, pelvic or puerperal sepsis, intra-abdominal sepsis
  • Skin and skin structure infections: Furuncle and abscess, cellulitis, wound infections
  • Bone and joint infections: Osteomyelitis
  • Dental infection: Dentoalveolar abscess
  • Other infections: Septicemia, peritonitis, post-surgical infections
  • Step down treatment for infections due to susceptible organisms, initially given antimicrobial therapy, particularly parenteral Co-amoxiclav.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.